Deborah M. Autor
Chief Policy Officer & DirectorMs. Deborah M. Autor, also known as Deb, JD, is Director of Amneal Pharmaceuticals LLC. Ms. Autor serves as Director at Hims & Hers Health, Inc. since November 2024 and is its Chief Policy Officer from November 2025. In this new role, she collaborates with other stakeholders, including consumers, telehealth platforms, providers, advocacy groups, medical associations, pharmaceutical companies, medtech innovators, policymakers and regulators, with the goal of paving the way to the healthcare of the future - where the power of technology would be combined with the best of personalized care. She leads the company’s global public policy, regulatory and government affairs functions. A former senior leader at the FDA, prosecutor for DOJ and leader in the pharma industry and nonprofit sector, she is a trusted visionary voice in health policy. She serves as Independent Director at Amneal Pharmaceuticals, Inc. since July 29, 2022. She has served as Independent Director at Pardes Biosciences, Inc. since July 2021. She served as Vice President, Global Head of Regulatory Excellence at AstraZeneca Pharmaceuticals LP from September 2019 to December 2021, where she led regulatory operations, policy and intelligence for all AstraZeneca’s submissions globally. She had been Senior Vice President of Strategic Global Quality and Regulatory Policy at Mylan N.V., since 2016. Ms. Autor served as Senior Vice President and Head Global Quality at Mylan N.V. from April 2013 to 2016. Ms. Autor was employed by Mylan NV from June 2013 to August 2019. She served as a Director and Associate Director in the Center for Drug Evaluation and Research Office of Compliance at The Food and Drug Administration from 2001 to 2011 and its Deputy Commissioner of Global Regulatory Operations and Policy from 2011 to 2013, where she oversaw all FDA inspections, criminal investigations and international operations for human and veterinary drugs, biologics, medical devices, tobacco and food. Ms. Autor was employed by the FDA from September 2001 to May 2013 in a variety of roles. Prior to joining FDA, she represented the agency as a litigator at the U.S. Department of Justice (DOJ). She served as Associate at Weil, Gotshal & Manges and Buc Levitt & Beardsley from 1992 to 1995. She had been a Director of Parenteral Drug Association since December 2014. She serves as Chair of the Board of Directors at FDA Alumni Association since 2019. She serves as Board Member at Antimicrobial Resistance Industry Alliance since 2018. She serves as Advisory Group Member of United States Pharmacopoeia Quality Institute since 2017. She serves as Member on the Centre for Innovation in Regulatory Science — Scientific Advisory Council. In recognition of her contributions to public health, she was awarded the 2011 Meritorious Executive Presidential Rank Award, the 2011 Food and Drug Law Institute’s Distinguished Service and Leadership Award and was a 2010 finalist for the prestigious Service to America Medal and was also honored as a "Great Federal Employee" on the Senate Floor in 2010. Ms. Autor obtained her B.A. in psychology from Barnard College of Columbia University and her J.D. magna cum laude from Boston University School of Law, where she was an Article Editor for the Boston University Law Review.
公司職務
- 公司名稱Hims & Hers Health, Inc.股票代碼HIMS職務Chief Policy Officer & Director共事同僚
- ADAndrew DudumCo-Founder, Chairman & CEO
- OOOluyemi OkupeChief Financial Officer
- MCMike ChiChief Operating Officer
- MEMohamed ElShenawyChief Technology Officer
- STSoleil Teubner BoughtonChief Legal Officer & Corporate Secretary
- DBDavid Bolling WellsLead Independent Director
- AGAndrea G. Perez GarciaIndependent Director
- CDChristopher D. PayneIndependent Director
